Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Corp VP,Quality&Transformation | September 11, 2019 | September 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date September 11, 2019 · Filed September 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,231 |
Reported balance
After 2019-09-11 transaction · row 1
1 source rowRow 1 · 2019-09-11 · Sale · Disposed 910 · Balance 8,231 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.7177 to $63.7183. |
Filing footnotes · ownership attribution and instrument terms
F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.7177 to $63.7183.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2019 Filed Sep 13, 2019 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 910 | $63.72 | $57,983.56 |
DisclosureSEC source: 0001209191-19-049473 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Quality&Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,231 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.7177 to $63.7183. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 72 | $56.14 | $4,042.08 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 7 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,141 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 267 | $56.14 | $14,989.38 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 6 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,213 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,962 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · derivative · entry 8 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,962 Underlying: Common Stock · 2,962 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 5 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,480 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 63 | $55.91 | $3,522.33 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 4 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,818 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 60 | $55.91 | $3,354.60 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,881 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 133 | $55.91 | $7,436.03 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,941 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 234 | $55.91 | $13,082.94 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,074 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,308 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,823 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,973 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 346 | $43.74 | $15,134.04 |
DisclosureSEC source: 0001209191-19-002113 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,001 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 174 | $54.15 | $9,422.10 |
DisclosureSEC source: 0001209191-18-021810 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 174 | $54.15 | $9,422.10 |
DisclosureSEC source: 0001209191-18-021810 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,521 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 259 | $56.14 | $14,540.26 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · nonDerivative · entry 5 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,695 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 70 | $56.14 | $3,929.80 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · nonDerivative · entry 4 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,954 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,549 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · derivative · entry 6 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 2,549 shares Expires 2026-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2018. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 233 | $56.23 | $13,101.59 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,024 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 62 | $56.23 | $3,486.26 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,257 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 659 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019852 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,319 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 6,800 | $54.13 | $368,050.00 |
DisclosureSEC source: 0001209191-18-018861 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,660 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $54.1 to $54.15. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,460 F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,611 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,669 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:05 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-000773 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,035 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 476 | $42.74 | $20,344.24 |
DisclosureSEC source: 0001209191-17-023014 · doc4.xml · nonDerivative · entry 4 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,834 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 477 | $42.74 | $20,386.98 |
DisclosureSEC source: 0001209191-17-023014 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,310 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 207 | $42.35 | $8,766.45 |
DisclosureSEC source: 0001209191-17-023014 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,787 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 208 | $42.35 | $8,808.80 |
DisclosureSEC source: 0001209191-17-023014 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,994 Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,670 | $43.48 | $72,603.25 |
DisclosureSEC source: 0001209191-17-021392 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,202 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 83 | $43.03 | $3,571.49 |
DisclosureSEC source: 0001209191-17-020802 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,872 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 318 | $43.03 | $13,683.54 |
DisclosureSEC source: 0001209191-17-020802 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,955 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,655 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-17-020802 · doc4.xml · derivative · entry 4 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,655 Underlying: Common Stock · 2,655 shares Expires 2025-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020802 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,273 Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012186 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,586 F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 612 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012186 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,644 F3 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 33% of the shares will vest on March 23, 2017, the second anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012186 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,032 F1 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 24, 2014 Performance Stock Award. Accordingly, 34% of the shares will vest on March 24, 2017, the third anniversary of the grant date. F2 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date and one additional unit of unvested performance based restricted stock ("PSU") for each PSU owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.